Literature DB >> 17063829

The effect of "Zusanli" (ST. 36) acupuncture on the bio-availability of sodium pertechnetate in Wistar rats.

Vasco Senna-Fernandes1, Daisy França, Silvana F R Moreno, Sebastião Santos-Filho, Philip A M Rogers, Mario Bernardo-Filho, Marco Antônio Mello Guimarães.   

Abstract

The effect of acupuncture stimulation at Zusanli point (ST.36) on the bioavailability of radio-pharmaceutical 99mTc-sodium pertechnetate (Na99mTcO4) in Wistar rats was investigated. Ten healthy rats were allocated into two groups of five. Group 1 (n=5) was treated by acupuncture by inserting stainless steel needles bilaterally at ST.36; Group 2 was the untreated control. Ocular plexus administration of 0.3ml of Na99mTcO4 (3.7MBq) was carried out 10 minutes after every needle insertion. The rats were killed 25 minutes later. The organs were isolated, the radioactivity determined in a well gamma counter, and the percentage of injected radio-pharmaceutical dose per gram of tissue (%ID/g) was assessed for each organ. The %ID/g varied significantly (p<0.05) between Group 1 and Group 2 in pancreas (0.91 +/- 0.17 vs 0.15 +/- 0.03), stomach (7.97 +/- 0.68 vs 3.51 +/- 0.22), spleen (0.97 +/- 0.11 vs 0.41 +/- 0.14), brain (0.19 +/- 0.09 vs 0.09 +/- 0.04), kidneys (0.91 +/- 0.17 vs 0.15 +/- 0.03), heart (0.81 +/- 0.17 vs 0.31 +/- 0.02) and testis (0.46 +/- 0.04 vs 0.14 +/- 0.03). These findings suggest that the effect of acupuncture at ST.36 modulated organs and tissues responses in rats. Using Chinese theories of Zang-Fu and Five Phases, we suggest that the relationship between acupoints and organs may be related to neuromodulation mechanisms such as somatovisceral reflex responses, which play an important role in the autonomic nervous system. These results also suggest that the effect of acupuncture on the bio-availability of radio-pharmaceuticals may help our understanding of the action of acupuncture points on various organs and tissues.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17063829     DOI: 10.3727/036012906815844328

Source DB:  PubMed          Journal:  Acupunct Electrother Res        ISSN: 0360-1293            Impact factor:   0.143


  6 in total

1.  Spike-sorting analysis of neural electrical signals evoked by acupuncture based on model.

Authors:  Qing Qin; Yajiao Liu; Bonan Shan; Yanqiu Che; Chunxiao Han; Yingmei Qin; Ruofan Wang; Jiang Wang
Journal:  Cogn Neurodyn       Date:  2020-11-28       Impact factor: 5.082

2.  Acupuncture at "Zusanli" (St.36) and "Sanyinjiao" (SP.6) Points on the Gastrointestinal Tract: A Study of the Bioavailability of (99m)Tc-Sodium Pertechnetate in Rats.

Authors:  Vasco Senna-Fernandes; Daisy L M França; Deise de Souza; Kelly C M Santos; Rafael S Sousa; Cristiano V Manoel; Sebastião D Santos-Filho; Célia M Cortez; Mario Bernardo-Filho; Marco Antonio M Guimarães
Journal:  Evid Based Complement Alternat Med       Date:  2010-10-18       Impact factor: 2.629

Review 3.  Acupoint-specific, frequency-dependent, and improved insulin sensitivity hypoglycemic effect of electroacupuncture applied to drug-combined therapy studied by a randomized control clinical trial.

Authors:  Rong-Tsung Lin; Chung-Yuh Tzeng; Yu-Chen Lee; Ying-I Chen; Tai-Hao Hsu; Jaung-Geng Lin; Shih-Liang Chang
Journal:  Evid Based Complement Alternat Med       Date:  2014-06-16       Impact factor: 2.629

4.  Effect of electrical stimulation combined with diet therapy on insulin resistance via mTOR signaling.

Authors:  Siqin Huang; Nianzhen Tang; Hongdi Zhao; Cheng-Lin Tang
Journal:  Mol Med Rep       Date:  2019-10-30       Impact factor: 2.952

5.  How does moxibustion possibly work?

Authors:  Jen-Hwey Chiu
Journal:  Evid Based Complement Alternat Med       Date:  2013-03-27       Impact factor: 2.629

6.  Electroacupuncture and rosiglitazone combined therapy as a means of treating insulin resistance and type 2 diabetes mellitus: a randomized controlled trial.

Authors:  Rong-Tsung Lin; Huei-Chin Pai; Yu-Chen Lee; Chung-Yuh Tzeng; Chin-Hsien Chang; Pei-Hsiu Hung; Ying-I Chen; Tai-Hao Hsu; Chin-Chun Tsai; Jaung-Geng Lin; Shih-Liang Chang
Journal:  Evid Based Complement Alternat Med       Date:  2013-07-29       Impact factor: 2.629

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.